Autoimmune thyroid disease (AITD) is the most common autoimmune disease that causes hypothyroidism. High iodine is a well-known factor that can induce thyroid disorders, including Hashimoto's thyroiditis, one of the main types of AITD. Recent epidemiological studies have indicated that phthalates, especially di-n-butyl phthalate (DBP) may induce thyroid disease. In this study, we aim to determine the effects and underlying mechanisms of high iodine and/or DBP exposure on AITD. Female Wistar rats were modeled with thyroglobulin and exposed to high iodine and/or DBP. We investigated histopathological changes in the thyroid and measured thyroid hormone levels in serum to assess thyroid function. In the thyroid and liver, we detected oxidative stress, proinflammatory factors (IL-1b, IL-6, and IL-17) and the activation of activator protein 1 (AP-1), a transcription factor that is related to the synthesis of the thyroxine-binding globulin (TBG) and the activation of Th17. After blocking AP-1 with SP600125, we detected TBG and the Th17 related cytokines . The data showed that thyroid damage and the alteration of thyroid hormones were greater when the rats were exposed to both high iodine and DBP. Coexposure to DBP and high iodine enhanced the activation of AP-1 in the liver and thyroid, and induced an increase in the levels of TBG in serum and IL-17 in the thyroid. Blocking AP-1 activation prevented the increase of TBG and IL-17. The results indicate that high iodine and/or DBP exposure exacerbated AITD through altering TBG levels in serum and aggravating IL-17 in the thyroid.
excessive iodine intake due to animal feed (including grass) containing high levels of iodine, and/or the use of iodophor cleaners for milk cans (Franke et al., 2009) . Nutritional supplements are also sources of excess iodine. It has been reported that maternal nutritional supplements during pregnancy can lead to congenital hypothyroidism (Connelly et al., 2012) .
More and more reports now indicate that other environmental chemicals such as phthalates, also interfere with thyroid function (Boas et al., 2006) . Phthalates are widely used as plasticizers in various commercial products. One study found that in adult men, the serum level of total triiodothyronine (T3) and free thyroxine (T4) existed in a negative relationship with concentrations of metabolites of di(2-ethylhexyl) phthalate (DEHP) (Meeker et al., 2007) . A study carried out in Taiwan found that the concentrations of metabolites of di-n-butyl phthalate (DBP) in urine samples from pregnant women showed a negative relationship with serum levels of total and free T4 (Huang et al., 2007) . Moreover, a study of 4-to 9-year-old children indicated that urinary phthalates, especially the metabolites of DEHP and DBP, had a negative relationship with physiological parameters associated with the thyroid (Boas et al., 2010) . Experimental studies have shown that phthalates can disturb T3-binding to transport proteins, that they can interact with the T3-uptake system on the plasma membrane, or that they can interfere with thyroid receptors (Boas et al., 2006; Huang et al., 2007; Meeker et al., 2007) . A study aimed at women in early pregnancy suggested that DBP may alter human T4 through interacting with thyroxine-binding globulin (TBG) .
Both phthalates and high iodine are common in our daily life and can interfere with thyroid function but we don't yet know what impact combined exposure to these 2 substances will have on the occurrence of AITD, nor do we understand the underlying mechanisms.
In this study, we focus primarily on TBG which carries 75% of the total T4 and 70% of the total T3 under normal circumstances (Hayashi et al., 1993) . TBG is synthesized in the liver and there are several activator protein 1 (AP-1) like recognition sequences (TGA G / C TCA) that bind c-Fos/c-Jun heterodimers in the TBG complete sequence. The synthesis of TBG is regulated by AP-1 (Hayashi et al., 1993) . As we know, phthalates can lead to oxidative stress and inflammatory injury in the liver, and that oxidative damage or inflammatory factors activate AP-1 (Chiu et al., 2010; Ma et al., 2014; Tharappel et al., 2001; Twaroski et al., 2001) . We therefore speculate that TBG synthesis and activation of AP-1 in the liver may be involved in a DBP-induced thyroid function disorder.
IL-17 is a key factor for autoimmune disease. IL-6, which induces IL-17 production, is regulated by AP-1 (Bettelli et al., 2007; Shen et al., 2015; Szabo-Fresnais et al., 2008; Zhou et al., 2007; Zhu and Qian, 2012) . DBP and high iodine aggravated AITD may also be related to the activation of AP-1 in the thyroid and the increase of IL-17. In the present study, we developed an experimental autoimmune thyroiditis rat model, and detected oxidative stress markers (reactive oxygen species [ROS] glutathione [GSH]), inflammatory cytokines , the level of TBG in serum, and the level of c-Jun phosphorylation to reflect AP-1 activation. In addition, SP600125, a common inhibitor of AP-1, was used to help us judge the role of AP-1 (Nagata et al., 2009) .
MATERIALS AND METHODS
Animals. Four-week old, specific pathogen free (SPF) female Wistar rats were purchased from the Hubei Experimental Animal Center (Wuhan, China). We used young female rats in our study because a research has indicated that the exposure levels of phthalates in children is probably higher than in adults when taking into account body weight, and that women have a greater risk of thyroid function disorder than do men (Koch et al., 2007; McLeod and Cooper, 2012) . All rats were housed under SPF conditions at 24 C-26 C with 55%-75% humidity and a 12-h light/dark cycle. Commercial food and filtered water were available ad libitum. Rats were quarantined for !7 days prior to the study. Each group included 7 mice to ensure statistical validity while minimizing the number of experimental animals used. The rats were kept in independent ventilation cages, each cage being equipped with separate air inlet and outlet systems. Experimental design. Nine groups of rats (n ¼ 7) were used in this study. These 63 total rats were randomly allocated to the 9 groups: (1) saline exposure group (saline group); (2) thyroglobulin modeling group (TG group); (3) high iodine with thyroglobulin group (HI þ TG group); (4) DBP with thyroglobulin group (DBP þ TG group); (5) high iodine plus DBP with thyroglobulin group (HI þ DBP þ TG group); (6)-(9) were SP600125 blocked groups
Immunization with thyroglobulin is a classic method to induce autoimmune thyroiditis in a rat. In our experiment, each rat was sensitized with thyroglobulin (150 lg thyroglobulin in 75 ll of saline that had been emulsified with an equal volume of CFA) on day 1 by intraperitoneal (i.p.) injection. On the 15th and 29th days, the rats received a booster injection of thyroglobulin (150 lg thyroglobulin in 75 lL of saline emulsified with an equal volume of IFA).
The WHO report has shown that daily iodine intakes of 1000 lg appear to be entirely safe (Unit, 1994) . We therefore chose 1000 lg/d to be the lower boundary value for the high iodine group. Taking into consideration the daily water consumption of rats, we gave the rats drinking water containing 1310.5 lg/l potassium iodide (yielding an iodine concentration of 1000 lg/l) until the 35th day. Based on a rats' lowest-observed-adverse-effect-level of 2 mg/kg bw/d, the European Food Safety Authority panel on food additives, flavorings, processing aids, and materials in contact with food has allocated a tolerable daily intake (TDI) for DBP of 0.01 mg/kg bw/d in 2005 (Lhuguenot, 2009 ). The daily DBP intake for children can be twice that of the TDI (Koch et al., 2007) . We therefore chose 4 mg/kg as the exposure concentration for this study. The dose of DBP that the rat is orally exposed to is 10 ml/kg, so DBP was dissolved in Tween-80 (DBP: Tween-80 is 1:1 in v/v) after which sterile saline solution was added to obtain a final concentration of 0.4 mg/ml. The SP600125 blocking groups received 5 mg/kg SP600125 via i.p. injection every week. All rats were sacrificed on day 36 and used for further biomarker detection and histological analysis. The detailed treatment schedule is shown in Figure 1 .
The thyroid glands and livers of rats from each group were collected and fixed in 10% neutral buffered formalin for 24 h at 25 C. These organs were then embedded in paraffin, cut into slices, and these sections stained with H&E (hematoxylin and eosin). All pathological sections were examined using a DM 4000B Microscope (Leica, Berlin, Germany). Tissue sections were qualitatively examined by an individual blind to the treatment groups.
Enzyme-linked immunosorbent assay. Serum was collected to determine the concentrations of TG-Ab, TT3, TT4, FT3, FT4, and TBG. A supernatant of 5% thyroid gland tissue homogenate was collected to measure the concentrations of IL-6 and IL-17. These biomarkers were measured using ELISA kits according to the manufacturer's instructions. The sensitivities of the kit were 15 pg/ml for both IL-6 and IL-17.
Detection of ROS and GSH. Supernatants of 10% liver tissue homogenate and of 5% thyroid gland tissue homogenate were collected to determine the levels of ROS and GSH.
To reflect ROS levels in the liver and thyroid gland, we used DCFH-DA, the most widely used probe for detecting H 2 O 2 (Bass et al., 2016) . Briefly, the liver tissue supernatants were diluted 200-fold with PBS (pH ¼ 7.5) while the supernatants of the thyroid gland were diluted 25-fold with PBS (pH ¼ 7.5). 100 ll of the diluted solution was mixed with 100 ll 10 lmol/l DCFH-DA. The reaction mixture was incubated in the dark for 30 min at 37 C, the fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 525 nm using a Fluorescence microplate reader (FLx 800; BioTek Instruments, Winooski, Vermont). The GSH concentrations in liver and thyroid tissues were determined using a GSH test kit. All operations were performed according to the manufacturer's instructions. The protein concentration was determined using the folin-phenol method protein assay kit.
Immunohistochemistry for IL-4, IFN-c, IL-1b, and c-Jun phosphorylation. Sections of the thyroid gland and liver tissues were deparaffinized, rehydrated and subjected to antigen retrieval. The sections were incubated with 0.3% hydrogen peroxide and blocked by normal serum. Sections were then incubated at 4 C overnight with the monoclonal antibodies: antiIL-4
and antiIFN-c (Boster Bio-engineering, Wuhan, China), antiIL-1b (Bioss, Beijing, China), and antiphospho-c-Jun (Abcam, Massachusetts). After incubation with the primary antibodies, the sections were incubated with an appropriate biotinylated immunoglobulin and avidin-biotin peroxidase complex. Using DAB complexes visualized the reaction product. The negative control was obtained by omitting the primary antibody. Sections were then washed and counterstained with hematoxylin, dehydrated, cleared and mounted in DPX (Sigma-Aldrich).
The average optical density of immunohistochemistry in each sample was analyzed using Image-Pro Plus software (Image-Pro Plus 6.0, Media Cybernetics).
Statistical analysis. Data are presented as mean 6 SEM. Statistical graphs were generated by GraphPad 5.0 (San Diego, California). The significance of variation among groups was determined by a 1-way ANOVA combined with Tukey's multiple comparison tests. p < .05 was considered significant and p < .01 was considered extremely significant. Data analyses were carried out using SPSS ver13 (Chicago, Illinois).
RESULTS

DBP and High Iodine Aggravated AITD Induced by Thyroglobulin
Serum autoantibody TG-Ab levels and the balance between Th1/Th2 were used to assess the impact of DBP and high iodine exposure on AITD. Figure 2A shows the levels of TG-Ab in all groups. In all thyroglobulin-immunized groups, the levels of TG-Ab increased extremely significantly (p < .01) compared with the saline group. Compared with the TG group, exposure to high iodine did not induce a significant change in TG-Ab, but DBP, or DBP and high iodine coexposure resulted in a significant increase in TG-Ab (p < .05). Interestingly, administering SP600125, the specific inhibitor of AP-1 (Nagata et al., 2009), significantly (p < .05) decreased the levels of TG-Ab in all exposure groups, indicating that AP-1 may play a certain role in high iodine and DBP exacerbation of experimental autoimmune thyroiditis induced by thyroglobulin. IFN-c and IL-4, the typical cytokines of Th1 and Th2 respectively, were measured to estimate the lymphocyte cytokine response. As shown in Figures 2B-2F , the levels of IL-4 did not change significantly among these experimental groups. But the IFN-c levels in all exposure groups showed an extremely significant (p < .01) increase compared with the saline group. When compared with the TG group, the IFN-c levels in the DBP þ TG group and the HI þ DBP þ TG group increased extremely significantly (p < .01). The HI þ TG group however showed no significant increase (p > .05). Compared with the DBP or high iodine exposure groups, the levels of IFN-c in the HI þ DBP þ TG group increased extremely significantly (p < .01). After blocking the AP-1 by SP600125, the exacerbation of IFN-c in the DBP þ TG group and the HI þ DBP þ TG group was significantly lower (p < .05).
We next investigated possible changes to the thyroid tissue structure. H&E staining was used to assess any histopathological injury to the thyroid. As shown in Figure 3 , in the HI þ TG group, follicles appear in the stratified epithelium and have become smaller than those in the control group. The number of follicles increased markedly. In the DBP group, we see lymphocytic infiltration and the walls of the follicles become thinner than those in the control group. In the HI þ DBP þ TG group, the follicles experienced breakage and a mass of lymphocytic infiltration. However, in the SP600125 treatment groups, the structural injuries of the thyroid were greatly inhibited. DBP and High Iodine Affect Thyroid Hormone Levels. To investigate thyroid function, we measured the levels of thyroid hormones in the rats. First, we measured the levels of TT3 and TT4 in serum ( Figure 4A ). When compared with the TG group, the HI þ TG group, DBP þ TG group, and HI þ DBP þ TG group showed an increase in TT3 levels (p < .05), whereas the DBP þ TG group, and HI þ DBP þ TG group demonstrated a significant increase in TT4 levels (p < .05). When compared with HI þ TG group, the levels of TT4 in HI þ DBP þ TG group showed a significant increase (p < .05).
We then measured FT3 and FT4 levels in serum to reflect the available thyroid hormones in rats ( Figure 4B ). Interestingly, in contrast to TT3 and TT4, the levels of FT4 in the DBP þ TG group decreased significantly (p < .05) compared with that of the TG group. The HI þ DBP þ TG group showed a significant decrease (p < .05) in FT4 levels compared with that of the TG group or HI þ TG group. Groups exposed to DBP and/or high iodine showed a significant decrease (p < .05) compared with the TG group, in the levels of FT3. Meanwhile, the level of FT3 in the HI þ DBP þ TG group demonstrated a significant decrease (p < .05) compared with the HI þ TG group and DBP þ TG group. It is noteworthy that treatment with SP600125 effectively alleviated the increase in TT3 and TT4, and inhibited the decrease in FT3, FT4.
The AP-1 Activated Status in the Liver and Changes in TBG Levels
Since treatment with SP600125 contributed to the decrease of TG-Ab levels and changes in the thyroid hormones, we determined the status of c-Jun phosphorylation to investigate the conditions of AP-1 activation in the liver (Figs. 5B and 5C ). of IL-4, IFN-c, the ratio of IL-4 and IFN-c in the thyroid, respectively. *p < .05, **p < .01, significant difference compared with the saline group; NS p > .05, #p < .05, ## p < .01, TG group compared with exposure groups; && p < .01, high iodine exposure groups compared with DBP and high iodine exposure group; @@ p < .01, DBP exposure groups compared with DBP and high iodine exposure group; † p < .05, † † p < .01, different exposure groups compared with their respective SP600125 treatment groups (n ¼ 7). E and F. Immunohistochemistry for IL-4 and IFN-c in the thyroid (original magnification, 400Â). B, The concentration of free T3 and free T4 for the different exposure groups and their respective SP600125 treatment groups. #p < .05, ##p < .01, significant difference compared with the TG group; & p < .05, && p < .01, high iodine exposure groups compared with DBP and high iodine exposure group; @ p < .05, DBP exposure groups compared with DBP and high iodine exposure group; NS p > .05, † p < .05, † † p < .01, different exposure groups compared with their respective SP600125 treatment groups (n ¼ 7).
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Inboldboth the DBP and HI þ DBP þ TG groups, the levels of cJun phosphorylation increased significantly (p < .05) when compared with the TG group.
To clarify the mechanisms underlying the changes in the thyroid hormones induced by DBP exposure, we measured the levels of TBG. Interestingly, the TBG levels in the DBP and HI þ DBP þ TG groups increased extremely significantly (p < .01). Notably, after blocking AP-1 with SP600125, the level of TBG in these 2 groups was seen to sharply decrease (p < .01).
Oxidative Stress and Inflammation in the Liver. To ascertain how DBP and/or high iodine activated AP-1 in the liver, we assessed the levels of oxidative stress and inflammatory factors in the liver. We determined the levels of ROS and GSH ( Figure 6A ). When compared with the saline group, the TG group and the DBP and/or high iodine exposure groups showed a significant increase (p < .05) in ROS levels. The levels of ROS in the DBP þ TG and HI þ DBP þ TG groups increased significantly compared with the TG group, especially the HI þ DBP þ TG group (p < .01). In contrast to ROS, the GSH levels in the DBP and HI þ DBP þ TG groups showed a sharp decrease (p < .05) compared with the TG group.
Oxidative stress can induce inflammation and can also influence AITD, so we measured the levels of IL-1b. All exposure groups, especially the HI þ DBP þ TG group, presented a significant increase (p < .05) in the levels of IL-1b when compared with the TG group.
Oxidative Stress and Inflammation in the Thyroid Gland. We determined oxidative stress and inflammatory factor levels in the thyroid gland to investigate what impact DBP exposure and/or high iodine had on the thyroid gland (Figure 7 ). When compared with the TG group, the level of ROS in the HI þ DBP þ TG group increased extremely significantly (p < .01). And compared with the high iodine or DBP exposure groups, the ROS levels in the HI þ DBP þ TG group demonstrated an extremely significant increase (p < .01) or significant increase (p < .05), respectively. In contrast to ROS, the levels of GSH in the high iodine and DBP exposure groups decreased significantly (p < .05) compared with the TG group. Meanwhile, compared with the high iodine or DBP exposure group, the GSH levels in the HI þ DBP þ TG group demonstrated a significant decrease (p < .05) or extremely significant decrease (p < .01), respectively. The IL-1b level of the HI þ DBP þ TG group increased extremely significantly (p < .01) compared with the TG group and increased significantly compared with the HI þ TG group (p < .05).
The Increase of IL-17 in the Thyroid. The levels of c-Jun phosphorylation in the thyroid are similar to the liver (Figure 8) , and all exposure groups showed a significant increase (p < .05) compared with the TG group. IL-6 is the key factor that induces IL-17 production and is regulated by AP-1 (Zhou et al., 2007) . We examined the levels of IL-6 in the thyroid. It was found that DBP led to a significant increase in IL-6 (p < .01) compared with the TG group, and that SP600125 significantly inhibited this increase (p < .01). Similar to IL-6, the level of IL-17 in the DBP group also increased significantly (p < .01).
DISCUSSION
AITD is the most common cause of thyroid function disorder in adults, and is characterized by thyroid lymphocytic infiltration and high levels of serum thyroid antibodies (Wang et al., 2015) . We observed that the DBP and HI þ DBP exposure groups exhibited increased levels of TG-Ab in the serum, and histopathological examination showed that follicles experienced structural destruction. Our results indicate that exposure to DBP, or high iodine plus DBP could exacerbate TG-induced AITD.
Imbalance in the Th1/Th2 immune response is a basic cause of AITD, and Hashimoto's thyroiditis is predominantly a Th1 immune response (Mikos et al., 2014) . We detected the levels of IFN-c and IL-4 to assess any change in the balance of the Th1/ Th2 immune response in the thyroid. In this study, levels of IFN-c were found to apparently increase in the thyroglobulinimmunized rats exposed to high iodine plus DBP, while IL-4 levels did not differ significantly among the experimental groups. These results indicate that high iodine and DBP induce an imbalance in the Th1/Th2 response and lead to the exacerbation of Hashimoto's thyroiditis.
To further evaluate thyroid function, we measured the levels of thyroid hormones in serum. We observed that levels of TT3 and TT4 in serum increased significantly in the high iodine plus Figure 7 . Effect of different treatments on oxidative stress and IL-1b in the thyroid. A, ROS fluorescence and GSH content in the thyroid. B, The average optical density of IL-1b in the thyroid. * p < .05, ** p < .01, significant difference compared with the saline group; NS p > .05, # p < .05, ##p < .01, different exposure groups compared with the TG groups; &p < .05, &&p < .01, high iodine exposure groups compared with DBP and high iodine exposure group; @ p < .05, @@ p < .01, DBP exposure groups compared with DBP and high iodine exposure group (n ¼ 7). C, Immunohistochemistry for IL-1b in the thyroid (original magnification, 400Â). DBP group. We surmise that there may be 2 reasons causing this phenomenon. First, high iodine can increase the biosynthesis of thyroid hormones; and secondly, DBP and high iodine can destroy the thyroid gland follicle, the thyroid hormones that are stored in the follicle therefore enter the blood resulting in the increased levels of TT3 and TT4. In contrast to total T3 and T4, the levels of free T3, T4 showed a significant decrease in the DBP group and the high iodine plus DBP group.
TBG is the most important thyroid hormone transport protein in the human body (Bartalena, 1993) . We therefore inferred that the decrease of free thyroid hormones is related to these proteins and chose TBG as the detection target. We found that the levels of TBG in the DBP, and the high iodine plus DBP groups increased significantly, indicating that DBP and high iodine can alter the hormone levels in serum, affecting thyroid function.
To expound the alteration of TBG levels, we determined the levels of c-Jun phosphorylation so as to reflect the conditions of AP-1 activation. The results showed that DBP strengthened AP-1 activation in the liver. We also measured the oxidative stress and inflammatory factors in the liver. DBP combined with high iodine aggravates oxidative stress in the liver, and induces an increase in the levels of IL-1b. These results suggest that DBP plus high iodine induces oxidative damage and inflammation in the liver which then activates AP-1 leading to the increase in TBG levels, resulting in alterations to the levels of thyroid hormones in the blood. This is consistent with another report which studied the relationship between liver abnormalities and endocrine diseases (Burra, 2013) .
In addition to affecting the levels of thyroid hormones in the blood, DBP and high iodine can influence the thyroid gland directly. As the results show, DBP and high iodine aggravated oxidative stress in the thyroid gland, and induced an increase in IL-1b levels. As we know IL-17 plays a crucial role in autoimmune diseases (Bettelli et al., 2006; Yan et al., 2014) . So we determined IL-17 levels and related upstream molecules. From the results, we found that DBP and high iodine induced inflammation factor IL-1b, triggered the activation of AP-1, which then increased the levels of IL-6, resulting in increased expression of IL-17 as we had hypothesized. We also detected the levels of IL-6 and IL-17 in the SP600125 treatment groups to affirm the role of AP-1 in the increase of IL-17 expression. The results showed that the activation of AP-1 decreased, the resulting lower levels of IL-6 led to the reduction of IL-17.
This study shows that DBP and high iodine can exacerbate Hashimoto's thyroiditis from 2 aspects. On the one hand, DBP combined with high iodine aggravated the inflammatory response in the liver then strengthened the activation of AP-1 in the liver, thus leading to an increase of TBG expression. This in turn influenced the levels of free thyroid hormones in the blood, resulting in thyroid hormone disorder and exacerbating AITD. On the other hand DBP and high iodine also enhanced the activation of AP-1 in the thyroid gland leading to increased levels of IL-6 which result in an increase of the expression of IL-17 and an aggravation of inflammation in the thyroid. In this study we showed that DBP and iodine can, not only injure the thyroid gland causing abnormal T4 synthesis, but can also affect the synthesis of TBG in the liver leading to a significant decrease in the levels of FT3 and FT4, which has a serious impact on physiological function. All of these decrease thyroid function and exacerbate AITD.
Our findings in this study explain the aggravation effects of DBP and high iodine on AITD from the physiological and molecular pathways. However, the interaction between high iodine and DBP is still unclear and further investigations of deeper molecular mechanisms are needed. Moreover, another animal study has indicated that after oral treatment with DBP or monobutylphthalate (MBP), higher concentrations of free MBP in the urine may give rise to more severe testicular damage than MBP in its bound form (Foster et al., 1983) . Recent epidemiological investigations of free and total urinary phthalate metabolite concentrations among pregnant women in China indicated that the geometric mean urinary concentrations of free and total MBP are the highest in 293 urine samples (Zhu et al., 2016) . Further studies into the effects of free phthalate metabolites on thyroid function are needed. 
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